Conception 🤰🏽 in women with RMDs: a focus on pSD: ☑️Assisted reproductive technology use does not seem much higher in women with pSD ☑️Miscarriages are more likely to be recorded in women with RMDs ☑️ Control groups are 🔑 RMD Open rmdopen.bmj.com/content/10/4/e…

🔔 RDV le 18 décembre pour la Journée Française du Lupus Systémique ! 📍 À l’ICM de La Pitié-Salpêtrière ou 💻 via Zoom 📋 Inscription gratuite : [email protected] + d'infos : drive.google.com/file/d/1q88-X4… #Lupus #Santé #Médecine

Sjogren's syndrome #SS | Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome (NEPTUNUS-2) | Recruiting | Argetina, Australia, Brazil, US & other countries| #clinicaltrials | buff.ly/3WCeHMd

Web-Based Ecological Momentary Assessment Tool — The Future of #Sjögren’s Disease Clinical Practice? 📱 Daily ESSPRI Assessments ✅ High Usability 📊 Accurate Symptom Tracking 📉 Captures Significant Day-to-Day Variability 🔓 rmdopen.bmj.com/content/10/4/e…

2023 EULAR Recommendations on Management of Fatigue A 2023 EULAR task force has made recommendations to the approach and management of fatigue in patients with inflammatory rheumatic and musculoskeletal diseases (I-RMDs). buff.ly/3ZOQzZG

Are you a #Lupus parent? Are you a teen or young adults with #SLE? We have a research study for you! redcap.link/17jif6ty #lupuswarrior #curelupus #kidsgetlupustoo #lupusawareness #lupie #spoonie #rheumtwitter

Join myself and Souzi Makri as we host an exceptional #WAD #WorldArthritisDay webinar on the theme of Informed Choices, Better Outcomes. Three outstanding speakers & an engaged Q&A session

#SS | A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome | Recruiting | 12 locations in United States | #clinicaltrials | buff.ly/3Sz3AT2

#ResearchHighlight | JAK inhibitors improve RA pain #pain #rheumatoidarthritis #therapy Read the original article here: bit.ly/3ZWuZTc

📣To all physicians and health professionals involved in the care of people with RMDs! Are you aware of the #cardiovascular risk of your patients and of EULAR recommendations on this topic? Take this 10-minute survey and pls repost! Thanks! 👉🏻 survey-xact.dk/LinkCollector?…

🚨 Conception in women with primary Sjögren′s disease (pSS) ▶️ Assisted reproductive technology use does not seem much higher in women with pSS ▶️ Prospective and preconceptional follow-ups for cases and controls are needed 🔑 Grégoire Martin de Frémont 🗝️ rmdopen.bmj.com/content/10/4/e…

Le projet NECESSITY, soutenu par l'UE, vise à améliorer les traitements pour les patients atteints de Sjögren via de nouveaux critères d'évaluation, des biomarqueurs prédictifs, et un essai clinique multicentrique. Plus d'infos : necessity-h2020.eu Sjögren NeceSSity Project

jnj.com/health-and-wel…

🏥 The Newcastle Sjogren's Stratification Tool (NSST) identifies four symptom-based subtypes in Sjogren's disease, but understanding their stability over time is crucial for broader clinical adoption and trial design 📊 Analysis of 511 patients across two cohorts showed ~60%

Dites Air Caraïbes , il paraît que vous refusez un voyage à Coline et son chien d’assistance??? C’est très très moche en plus d’être illégal HANDI'CHIENS #DoublePeine Ça s’arrête quand le combat pour faire JUSTE appliquer la loi?

🔥This NEW editorial highlights topical #cyclosporineA (CsA) as a key immunomodulatory treatment for #dryeye disease in #SjögrensSyndrome 👉doi.org/10.5114/reum/1… The importance of individualized treatment approaches is emphasized.

The relationship between neuropathic pain and lower urinary tract symptom scores in patients with primary Sjögren’s bmcurol.biomedcentral.com/articles/10.11…

▶️ Sexual experience and functioning in male and female patients with Sjögren’s disease: a qualitative study 🧠💔 New study sheds light on the impact of #SjögrensDisease on sexual functioning in both women & men ⭐ 64% of women & 67% of men reported dysfunction. 🔺 Themes

🌟Very important subject that deserves to be highlighted. 👉 Neurological issues in #Sjögren are often reported by patients as a major #unmetneed. The webinar is free, open to everyone and will be moderated by our board member Coralie Bouillot Alessia Alunno Coralie Bouillot

« Everything You Always Wanted to Know About Clinical Trials (But Were Afraid to Ask) » Open and honest discussion with clinicians involved in research, patients and representatives from pharma. 🔗 Register now: lc.cx/oXeZkg #WSD2025 #SjögrenDisease #Unmetneeds